
|Videos|September 13, 2017
- Non-Small Cell Lung Cancer
- Volume 1
- Issue 1
Dr. Langer Discusses Current Treatment Strategies for Patients With Non-Driver Nonsquamous NSCLC
Corey J. Langer, MD, Perelman Center for Advanced Medicine, Hospital of the University of Pennsylvania, discusses current treatment strategies for patients with non-driver nonsquamous non-small cell lung cancer (NSCLC).
Advertisement
Articles in this issue
over 8 years ago
Current Treatment Strategies in Nonbiomarker Nonsquamous NSCLCover 8 years ago
Emerging Treatment Strategies in Nonsquamous NSCLCAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Multimodal AI Outperforms Oncotype DX in Predicting Late Breast Cancer Recurrence
2
T-DXd Benefit Consistent Across Subgroups in High-Risk HER2+ Breast Cancer
3
Sacituzumab Govitecan Improves QOL in Untreated Advanced TNBC
4
FDA Grants Priority Review to Nivolumab-AVD in Classical Hodgkin Lymphoma
5






































